Delivery Order SPE2DB20D1100-SPE2DB24FB8W8
Award Date
5/21/24
Potential Completion Date
5/22/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, a $1,081.34 firm fixed price delivery order, is for the provision of Pfizer COVID-19 vaccine doses in the 6-month to 4-year dosage form under the Emergency Use Authorization (EUA). The contract has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, as the prime...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,778.54 Firm Fixed Price Delivery Order is for the supply of Pfizer COVID-19 vaccine doses (0.9 ML) for the years 2024-2025 under the Food and Drug Administration's Emergency Use Authorization (EUA). The contract has an ultimate completion date of September 20, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds...
This federal contract award is for the delivery of Pfizer's COVID-19 vaccine over a period of 6 months to 4 years, under an Emergency Use Authorization. The $2,259.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen has a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,562.12 Firm Fixed Price delivery order is for the procurement of Pfizer COVID-19 vaccines (0.9 ml) to support the 2023-2024 vaccination program under the Emergency Use Authorization (EUA). The award has an ultimate completion date of February 7, 2024. AmerisourceBergen maintains a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,081.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Pfizer COVID-19 vaccines, under an Emergency Use Authorization (EUA), with an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.56 firm fixed-price delivery order is for the supply of 0.9 mL Pfizer COVID-19 vaccines for the 2024-2025 timeframe, under an Expanded Use Authorization (EUA). The contract has an ultimate completion date of November 15, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of Pfizer's COVID-19 vaccine under an Emergency Use Authorization (EUA) for a 6-month to 4-year period, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $2,138.52 firm fixed-price delivery order has a completion date of May 6, 2024. AmerisourceBergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
This federal contract award, valued at $12,391.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of the pharmaceutical distributor Cencora, Inc. The contract is a firm fixed price delivery order for the supply of 0.9ML doses of the Pfizer COVID-19 vaccine for the 2023-2024 timeframe, under the COVID-19 Emergency Use Authorization (EUA). The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,622.03 delivery order is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period, including 0.9 mL dosages under an Emergency Use Authorization (EUA). The contract has an ultimate completion date of March 14, 2025 and is a Firm Fixed Price delivery order. There was no set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,138.52 firm fixed price delivery order is for the supply of Pfizer COVID-19 vaccines (0.9ml) to support the Department of Defense during the 2023-2024 timeframe, including an extended use authorization (EUA) period. No set-aside designations were used for this award....